drugset / Trial / NCT01012414

Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease

NCT01012414 ↗

Phase 3 Terminated 10 enrolled Thomas Jefferson University Abbott · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if vitamin D supplementation changes the results of certain tests associated with inflammation in the body using an oral, synthetic form of vitamin D called paricalcitol.

Timeline

Start
2010-01
Primary completion
2011-05
Completion
2011-05

Outcome

Outcome not reported

Stopped (Enrollment): “Futility in enrollment as of May 31, 2011”

Drugs

EvaluationDrugModalityDoseRoute
Subject Paricalcitol Other / unclassified 2 ug Oral